A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Clinical trial NCT02326454 · COMPLETED
Trial details
- NCT number
- NCT02326454
- Sponsor
- Light Sciences Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-03-29
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.